Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

References for PMC Articles for PubMed (Select 23109709)

1.

B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity.

Khalil AM, Cambier JC, Shlomchik MJ.

Science. 2012 Jun 1;336(6085):1178-81. doi: 10.1126/science.1213368. Epub 2012 May 3.

2.

Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.

Baerenwaldt A, Lux A, Danzer H, Spriewald BM, Ullrich E, Heidkamp G, Dudziak D, Nimmerjahn F.

Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18772-7. doi: 10.1073/pnas.1111810108. Epub 2011 Nov 7.

3.

The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility.

Boross P, Arandhara VL, Martin-Ramirez J, Santiago-Raber ML, Carlucci F, Flierman R, van der Kaa J, Breukel C, Claassens JW, Camps M, Lubberts E, Salvatori D, Rastaldi MP, Ossendorp F, Daha MR, Cook HT, Izui S, Botto M, Verbeek JS.

J Immunol. 2011 Aug 1;187(3):1304-13. doi: 10.4049/jimmunol.1101194. Epub 2011 Jul 1.

4.

A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center.

Schwickert TA, Victora GD, Fooksman DR, Kamphorst AO, Mugnier MR, Gitlin AD, Dustin ML, Nussenzweig MC.

J Exp Med. 2011 Jun 6;208(6):1243-52. doi: 10.1084/jem.20102477. Epub 2011 May 16.

5.

Local renal autoantibody production in lupus nephritis.

Espeli M, Bökers S, Giannico G, Dickinson HA, Bardsley V, Fogo AB, Smith KG.

J Am Soc Nephrol. 2011 Feb;22(2):296-305. doi: 10.1681/ASN.2010050515. Epub 2010 Nov 18.

6.

Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.

Tiller T, Kofer J, Kreschel C, Busse CE, Riebel S, Wickert S, Oden F, Mertes MM, Ehlers M, Wardemann H.

J Exp Med. 2010 Nov 22;207(12):2767-78. doi: 10.1084/jem.20100171. Epub 2010 Nov 15.

7.

Genetic variation, Fcγ receptors, KIRs and infection: the evolution of autoimmunity.

Espeli M, Niederer HA, Traherne JA, Trowsdale J, Smith KG.

Curr Opin Immunol. 2010 Dec;22(6):715-22. doi: 10.1016/j.coi.2010.10.003. Epub 2010 Nov 1. Review.

PMID:
21050737
8.

Copy number, linkage disequilibrium and disease association in the FCGR locus.

Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JA, Urban BC, Peshu N, Dunstan SJ, Hien TT, Phu NH, Padyukov L, Gunnarsson I, Svenungsson E, Savage CO, Watts RA, Lyons PA, Clayton DG, Smith KG.

Hum Mol Genet. 2010 Aug 15;19(16):3282-94. doi: 10.1093/hmg/ddq216. Epub 2010 May 27.

9.

FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.

Smith KG, Clatworthy MR.

Nat Rev Immunol. 2010 May;10(5):328-43. doi: 10.1038/nri2762. Review. Erratum in: Nat Rev Immunol. 2010 Sep;10(9):674.

10.

A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus.

Willcocks LC, Carr EJ, Niederer HA, Rayner TF, Williams TN, Yang W, Scott JA, Urban BC, Peshu N, Vyse TJ, Lau YL, Lyons PA, Smith KG.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7881-5. doi: 10.1073/pnas.0915133107. Epub 2010 Apr 12.

11.

Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.

Jørgensen TN, Alfaro J, Enriquez HL, Jiang C, Loo WM, Atencio S, Bupp MR, Mailloux CM, Metzger T, Flannery S, Rozzo SJ, Kotzin BL, Rosemblatt M, Bono MR, Erickson LD.

J Immunol. 2010 Jan 15;184(2):775-86. doi: 10.4049/jimmunol.0901322. Epub 2009 Dec 16.

12.

Engineering the mouse genome to model human disease for drug discovery.

Koentgen F, Suess G, Naf D.

Methods Mol Biol. 2010;602:55-77. doi: 10.1007/978-1-60761-058-8_4.

PMID:
20012392
13.

The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints.

Vuyyuru R, Mohan C, Manser T, Rahman ZS.

J Immunol. 2009 Nov 1;183(9):5716-27. doi: 10.4049/jimmunol.0804215. Epub 2009 Oct 14.

14.

Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb.

Brownlie RJ, Lawlor KE, Niederer HA, Cutler AJ, Xiang Z, Clatworthy MR, Floto RA, Greaves DR, Lyons PA, Smith KG.

J Exp Med. 2008 Apr 14;205(4):883-95. doi: 10.1084/jem.20072565. Epub 2008 Mar 24.

15.

Fcgamma receptors as regulators of immune responses.

Nimmerjahn F, Ravetch JV.

Nat Rev Immunol. 2008 Jan;8(1):34-47. Review.

PMID:
18064051
16.

Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production.

Rahman ZS, Niu H, Perry D, Wakeland E, Manser T, Morel L.

Genes Immun. 2007 Oct;8(7):604-12. Epub 2007 Aug 23.

PMID:
17713556
17.

Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria.

Clatworthy MR, Willcocks L, Urban B, Langhorne J, Williams TN, Peshu N, Watkins NA, Floto RA, Smith KG.

Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7169-74. Epub 2007 Apr 13.

18.

FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.

Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, Walker EU, Manz RA, Tarlinton DM, Smith KG.

Nat Immunol. 2007 Apr;8(4):419-29. Epub 2007 Feb 18.

PMID:
17322888
19.

The B cell antigen receptor controls AP-1 and NFAT activity through Ras-mediated activation of Ral.

de Gorter DJ, Vos JC, Pals ST, Spaargaren M.

J Immunol. 2007 Feb 1;178(3):1405-14.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk